Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation
Cells · 21.09.2023 · 12 (18) · 2330
DOI: 10.3390/cells12182330 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 21.09.2023. Verfasst von Flora Tassone und 45 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA. Hauptthemen laut MEDLINE: Fragile X Syndrome, Fragile X Messenger Ribonucleoprotein 1. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 480 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH.
Abstract (Originalsprache)
The premutation of the fragile X messenger ribonucleoprotein 1 (FMR1) gene is characterized by an expansion of the CGG trinucleotide repeats (55 to 200 CGGs) in the 5’ untranslated region and increased levels of FMR1 mRNA. Molecular mechanisms leading to fragile X-premutation-associated conditions (FXPAC) include cotranscriptional R-loop formations, FMR1 mRNA toxicity through both RNA gelation into nuclear foci and sequestration of various CGG-repeat-binding proteins, and the repeat-associated non-AUG (RAN)-initiated translation of potentially toxic proteins. Such molecular mechanisms contribute to subsequent consequences, including mitochondrial dysfunction and neuronal death. Clinically, premutation carriers may exhibit a wide range of symptoms and phenotypes. Any of the problems associated with the premutation can appropriately be called FXPAC. Fragile X-associated tremor/ataxia syndrome (FXTAS), fragile X-associated primary ovarian insufficiency (FXPOI), and fragile X-associated neuropsychiatric disorders (FXAND) can fall under FXPAC. Understanding the molecular and clinical aspects of the premutation of the FMR1 gene is crucial for the accurate diagnosis, genetic counseling, and appropriate management of affected individuals and families. This paper summarizes all the known problems associated with the premutation and documents the presentations and discussions that occurred at the International Premutation Conference, which took place in New Zealand in 2023.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
- MIND Institute, University of California Davis, Davis, CA 95817, USA.
- Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11129 Belgrade, Serbia.
- Fragile X Clinic, Special Hospital for Cerebral Palsy and Developmental Neurology, 11040 Belgrade, Serbia.
- Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Victorian Clinical Genetics Services, Royal Children's Hospital, Melbourne, VIC 3052, Australia.
ORCID-Profile: Flora Tassone, Dragana Protic, Alison D Archibald, Dejan B Budimirovic, Jonathan Cohen, Lidia V Gabis, David Hessl, Peng Jin, Jessica Klusek, R Frank Kooy, Claudine M Kraan, Cecilia Laterza, Danuta Loesch, Reymundo Lozano, Apostolos Manolopoulos, Federica Alice Maria Montanaro, Sarah Nelson Potter, Melissa Raspa, Peter K Todd, Katarzyna Tutak, Marwa Zafarullah, Randi J Hagerman
Förderung
- NICHD NIH HHS
- NIH
Zitieren
APA
Tassone, F., Protic, D., Allen, E. G., Archibald, A. D., Baud, A., Brown, T. W., Budimirovic, D. B., Cohen, J., Dufour, B., Eiges, R., Elvassore, N., Gabis, L. V., Grudzien, S. J., Hall, D. A., Hessl, D., Hogan, A., Hunter, J. E., Jin, P., Jiraanont, P., …, & Hagerman, R. J. (2023). Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation. Cells, 12(18), 2330. https://doi.org/10.3390/cells12182330
Vancouver
Tassone F, Protic D, Allen EG, Archibald AD, Baud A, Brown TW, et al. Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation. Cells. 2023;12(18):2330. doi:10.3390/cells12182330
BibTeX
@article{Tassone2023,
author = {Tassone, Flora and Protic, Dragana and Allen, Emily Graves and Archibald, Alison D and Baud, Anna and Brown, Ted W and Budimirovic, Dejan B and Cohen, Jonathan and Dufour, Brett and Eiges, Rachel and Elvassore, Nicola and Gabis, Lidia V and Grudzien, Samantha J and Hall, Deborah A and Hessl, David and Hogan, Abigail and Hunter, Jessica Ezzell and Jin, Peng and Jiraanont, Poonnada and Klusek, Jessica and Kooy, R Frank and Kraan, Claudine M and Laterza, Cecilia and Lee, Andrea and Lipworth, Karen and Losh, Molly and Loesch, Danuta and Lozano, Reymundo and Mailick, Marsha R and Manolopoulos, Apostolos and Martinez-Cerdeno, Veronica and McLennan, Yingratana and Miller, Robert M and Montanaro, Federica Alice Maria and Mosconi, Matthew W and Potter, Sarah Nelson and Raspa, Melissa and Rivera, Susan M and Shelly, Katharine and Todd, Peter K and Tutak, Katarzyna and Wang, Jun Yi and Wheeler, Anne and Winarni, Tri Indah and Zafarullah, Marwa and Hagerman, Randi J},
title = {Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation},
journal = {Cells},
year = {2023},
volume = {12},
number = {18},
pages = {2330},
doi = {10.3390/cells12182330}
}
EUVIMED